Humacyte Newsroom

EF Hutton Initiates Coverage On Humacyte With Buy Rating, Announces Price Target of $25

BenzingaSep 9 19:57

EF Hutton Initiates Humacyte(HUMA.US) With Buy Rating, Announces Target Price $25

Futu NewsSep 9 19:33

Humacyte Price Target Maintained With a $15.00/Share by Benchmark

Dow JonesSep 6 00:52

Humacyte Analyst Ratings

BenzingaSep 6 00:42

Benchmark Co. Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $15

Futu NewsSep 5 20:31

Benchmark Co. Remains a Buy on Humacyte (HUMA)

TipRanksSep 5 19:44

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 27 23:32

Humacyte Analyst Ratings

BenzingaAug 14 22:17

Benchmark Reiterates Buy on Humacyte, Maintains $15 Price Target

BenzingaAug 14 22:17

Benchmark Co. Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $15

Futu NewsAug 14 19:34

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 14 04:32

Humacyte Analyst Ratings

BenzingaAug 13 01:01

TD Cowen Sticks to Its Buy Rating for Humacyte (HUMA)

TipRanksAug 12 19:35

Analysts Conflicted on These Healthcare Names: Edgewise Therapeutics (EWTX), Humacyte (HUMA) and Apellis Pharmaceuticals (APLS)

TipRanksAug 12 19:16

Humacyte (HUMA) Gets a Hold From Piper Sandler

TipRanksAug 12 19:14

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $10

Futu NewsAug 1 01:31

Buy Rating Affirmed for Humacyte Amid Superior ATEV Clinical Results and Market Opportunity

TipRanksAug 1 00:37

Humacyte Analyst Ratings

BenzingaJul 16 01:04

Humacyte Analyst Ratings

BenzingaJul 2 21:28

Humacyte (HUMA) Gets a Buy From Benchmark Co.

TipRanksJul 2 19:08